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Abstract This study reports that bilirubin^bovine L-lactoglo-
bulin (BLG) complexes exhibit very characteristic induced cir-
cular dichroism (CD) spectra in the visible absorption region.
Due to intramolecular chiral exciton coupling between the di-
pyrrinone chromophores, the long-wavelength negative and
short-wavelength positive CD bands clearly prove that a single
bilirubin molecule binds to BLG in a left-handed helical con-
formation (in pH 7.4 phosphate bu¡er vOmin is 354 M31 cm31
at 467 nm and vOmax is +48.5 M31 cm31 at 412 nm). The very
low aqueous solubility and strong tendency of bilirubin mole-
cules to aggregate around pH 7.4 meant that much more intense
CD bands were measured at alkaline pH values owing to the
increasing solubility of the ligand. Vanishing CD activity ob-
tained upon titration of the complex with palmitic acid known to
bind in the hydrophobic cavity of BLG indicates bilirubin to be
bound at the open end mouth of the L-barrel. Reversible changes
of the induced CD spectrum due to acidic pH shift of the sample
solution lead to the same conclusion.
3 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
In recent years, considerable attention has been focused on
the lipocalin protein family, of which members can be found
in bacteria [1], plant cells [2], insects [3], mammals [4] and
human body [5]. Lipocalins are small globular proteins typi-
cally comprising 160^180 residues designed mostly to bind
and transfer hydrophobic compounds with physiological im-
portance. To ful¢ll this function, they have an eight-stranded
L-barrel providing a large interior cavity suitable to bind li-
gand molecules, including retinoids, carotenoids, biliverdin,
pheromones, prostaglandins, steroid hormones and more
[6,7]. Aside from the conserved L-barrel, there are four £exible
loops at the open end of the hydrophobic pocket, of which
structural variabilities determine molecular recognition and
ligand speci¢city. With the aid of techniques from combina-
torial molecular biology, the structurally rigid lipocalin scaf-
fold [8] has recently been utilized to produce a novel class of
engineered proteins, the so-called anticalins, which can be
used ^ similarly to antibodies ^ for the detection of substances
or for the targeting of cellular surface markers [9,10]. High
a⁄nity and speci¢city of these proteins towards given molec-
ular structures make them promising tools for the wide ¢eld
of biomolecular/biotechnology researches. Thus, it is espe-
cially interesting to study the ligand-binding properties of nat-
ural lipocalins and the underlying molecular mechanisms.
Because of its abundance and ease of puri¢cation, bovine
L-lactoglobulin (BLG) found in cow milk has been studied
extensively for many years [11,12]. It is a small, 162 amino
acid globular protein of the lipocalin family composed of 10^
15% of K-helix structures and of ca. 50% of anti-parallel
L-sheet, forming a calyx in which small hydrophobic mole-
cules (i.e. fatty acids, vitamin A and its derivatives) have
been shown to be bound [13^15]. Bovine milk contains two
main genetic variants of BLG, named A and B. Variant B
di¡ers in the amino acid sequence at positions 64 (AspCGly
in var. B) and 118 (ValCAla in var. B). Around neutral pH
BLG is mainly dimeric, whereas near pH 3 it dissociates into
monomers. Furthermore, between pH 6.5 and 8.0 reversible
conformational change occurs in the loop region, the so-called
NCR or Tanford transition [16]. Depending on actual pH
values the EF loop (residues 85^90) blocks or opens the en-
trance of the calyx; it is closed at pH 6.2 and opened at pH
7.1 and 8.2 [17]. This conformational movement profoundly
alters ligand binding property of molecules into the hydro-
phobic pocket; lowering the pH value below 7, ligand^BLG
complexes dissociate in a reversible manner [18,19].
If an achiral ligand molecule having a good chromophore
(i.e. extended aromatic Z-system) becomes optically active
upon binding to a protein, then this interaction can sensitively
be traced by the circular dichroism (CD) spectroscopy method
[19,20]. Using this technique, this paper reports that BLG is
able to bind bilirubin (BR), the powerful antioxidant [21] li-
pophilic tetrapyrrole molecule which is the ¢nal product of
heme catabolism. This surprising result o¡ers a good oppor-
tunity to improve our knowledge of the molecular recognition
mechanism of lipocalins and opens new possibilities for study-
ing non-covalent interactions between BLG and other tetra-
pyrrole compounds having biochemical signi¢cance.
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2. Materials and methods
2.1. Materials
Cow milk L-lactoglobulin (L3908, a mixture of A and B variants;
L7880, variant A; L8005, variant B) and palmitic acid (P5585) was
obtained from Sigma and used as supplied. Crystalline BR (Sigma,
B4126, lot No. 117H12831; 88% BR IXK, 7% BR IIIK, 5% BR XIIIK)
was used without further treatment. Doubly distilled water and spec-
troscopy-grade dimethyl sulfoxide (DMSO; Scharlau Chemie, Barce-
lona, Spain) were used. All other chemicals were of analytical grade.
2.2. Preparation of L-lactoglobulin solution
To obtainV1034 M sample solution, BLG was dissolved in 0.05 M
pH 7.4 phosphate bu¡er solution. Protein concentration was deter-
mined spectrophotometrically from the UV spectrum of BLG by us-
ing a molar absorption coe⁄cient O278 nm = 17 600 M31 cm31 [22].
Molecular weight of a BLG monomer was taken to be 18 300.
2.3. Preparation of BR stock solution
Freshly prepared solutions were made up by dissolving the pigment
in DMSO to give 2U1033 M concentration. Stock solutions were
protected from light throughout the experiments. Concentration of
BR was determined by measuring its ultraviolet^visible (UV/Vis) spec-
trum in DMSO with O458 nm =64 000 M31 cm31 [23].
2.4. Stock solution of palmitic acid
2.25 mg of palmitic acid was dissolved in 2.2 ml DMSO to obtain
4.0U1033 M solution.
2.5. Circular dichroism and UV/Vis absorption spectroscopy
measurements
CD and UV/Vis spectra were recorded between 330 and 550 nm on
a Jasco J-715 spectropolarimeter at 20P0.2‡C in a rectangular cuvette
with 1 cm optical pathlength. Temperature control was provided by a
Peltier thermostat equipped with magnetic stirring. All spectra were
accumulated two or three times with a bandwidth of 1.0 nm and a
resolution of 0.2 nm at a scan speed of 100 nm/min. Induced CD is
de¢ned as the CD of the BR^BLG mixture minus the CD of BLG
alone measured at the same wavelengths and expressed as ellipticity in
millidegrees (mdeg).
2.6. Titrations of BLG A, BLG B and the mixture of A+B with BR in
pH 7.4 phosphate bu¡er solution at 20‡C
Three independent titration experiments were performed using the
genetic variants of BLG A, BLG B and the mixture of A+B. 2 ml
protein solution was placed in a rectangular cuvette with 1 cm optical
pathlength and small amounts of BR stock solution were added with
an automatic pipette in 2.5 Wl aliquots (cBLG A = 9.1U1035 M,
cBLG B = 8.1U1035 M, cBLG AþB = 9.0U1035 M). Initial and ¢nal con-
centrations of BR were 2.5U1036 M and 4.2U1035 M, respectively.
DMSO added with the ligand never exceeded 3% (v/v).
2.7. Measuring the induced CD and UV/Vis spectra of the BR^BLG
complex at alkaline pH values
25 Wl BR stock solution was added to 2 ml of 8.9U1035 M BLG
solution (a mixture of A and B variants) prepared in 0.05 M pH 7.4
phosphate bu¡er solution (cBR =2.1U1035 M). After recording the
CD and absorption spectra, Wl volumes from 2 M NaOH solution
were pipetted into the cuvette consecutively to achieve pH values of
7.7, 8.0, 8.2, 8.7 and 9.6 (t=20‡C). Spectra were taken at each pH
value.
2.8. Titration of the BR^BLG complex with palmitic acid
25 Wl BR stock solution was added to 2 ml of 9.0U1035 M BLG
solution (a mixture of A and B variants) in a rectangular cuvette with
1 cm optical pathlength. After formation of the complex, palmitic acid
stock solution in 2.5 Wl aliquots was added consecutively to achieve
complete extinction of the induced CD signals.
2.9. Investigation of the acidic pH shift on the induced CD spectrum of
the BR^BLG complex
25 Wl BR stock solution was added to 2 ml of 8.9U1035 M BLG
solution (a mixture of A and B variants) in a rectangular cuvette with
1 cm optical pathlength (cBR = 2.1U1035 M). After recording the CD/
UV/Vis spectra, the pH of the solution was measured (7.51). Then the
pH value was decreased to 6.49 by mixing 50 Wl 1 M HCl into the
sample solution and a spectral measurement was taken again. Finally,
the pH value was set back to 7.66 with addition of 30 Wl 2 M NaOH.
For pH measurements, a digital pH meter (OP-115; Radelkis, Bu-
dapest, Hungary) with a combined glass electrode (OP-0864 P; Ra-
delkis) was used.
3. Results and discussion
Despite its polar functionalities, BR is a strongly hydro-
phobic molecule due to extensive intramolecular hydrogen
bonds formed between the propionic acid and lactam moi-
eties. In solution, BR exists as an equimolar mixture of two
intramolecularly hydrogen-bonded non-superimposable con-
formational isomers of P (plus) and M (minus) helicity re-
ferred to as ‘ridge tile’ structures in which the dipyrrinone
chromophores are approximately perpendicular to each other
Fig. 1. Interconverting mirror image conformations of BR. Double-headed arrows show polarization of long-wavelength electronic dipole tran-
sition moments of dipyrrinone chromophores; dashed lines denote intramolecular hydrogen bonds. The relative orientation of dipole moments
de¢nes the helicity of the chiral conformers (M=minus or left-handed; P=plus or right-handed). The ¢gure is taken from [25] by permission.
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(Fig. 1) [24]. According to the mirror image relation of these
interconverting conformers, BR shows no optical activity ei-
ther in organic or aqueous solutions. However, if BR mole-
cules interact with external chiral complexing agents (i.e. se-
rum albumin, cyclodextrines, etc.) the equilibrium is shifted
and, due to the excess of the P or M conformers, induced
optical activity can be measured [24^26].
In the presence of BLG, which itself shows neither light
absorption nor CD activity above 330 nm, BR exhibits de¢-
nite, oppositely signed CD bands in the visible spectral region
(Fig. 2). Long- and short-wavelength Cotton e¡ects (CE) ap-
pear centered at 467 and 412 nm, respectively, with a zero
cross-over point at 434 nm matched nearly with the maximum
of the intense absorption band of BR. On the one hand, these
induced CD spectra give proof of the binding of BR to BLG.
On the other hand, the bisignate nature of CD curves suggests
intramolecular chiral exciton coupling to occur between the
electric dipole transition moments of dissymmetrically posi-
tioned dipyrrinone chromophores. According to the exciton
chirality rule [24], the signed order of the induced CEs (a long-
wavelength negative CE followed by a positive short-wave-
length one) indicates BR molecules to bind to BLG in a
left-handed chiral conformation (M-helicity, Fig. 1). It is im-
portant to note that such exciton CD bands might stem from
intermolecular interactions between two neighboring, protein-
bound ligand molecules (intermolecular exciton coupling).
This possibility, however, can be ruled out by the facts that
induced CEs appear far below a ligand/protein molar ratio
(L/P) of 1 and their shapes and spectral positions show no
changes upon further addition of BR. Thus, it can be con-
cluded that single, BLG-bound BR molecules are responsible
for the observed induced CD spectrum.
It is worthwhile to note that the interaction between BR
and BLG has already been investigated by the £uorescence
spectroscopy method and solid-phase binding assay [27]. Since
neither signi¢cant quenching of the intrinsic £uorescence of
BLG nor binding in the solid-phase assay were observed, the
authors concluded that BLG does not bind BR. It is not clear
why these methods showed no interaction between BR and
BLG.
In the course of the titration of BLG with BR the intensities
of the induced CD bands increase with the added amount of
the ligand, but above 0.33 BR/BLG molar ratio ellipticity
values become constant (321 mdeg at 467 nm and +18
mdeg at 412 nm), showing no changes despite further addition
of BR (Fig. 3). Practically the same results were obtained
using the A and B genetic variants of BLG alone, suggesting
that there are no signi¢cant di¡erences in the BR binding
properties of the two isoforms (Fig. 3; for clarity, data points
of the BLG B^BR complex are omitted). To understand
that saturation of the CD titration curves already occurs at
L/P= 0.30^0.35 (Fig. 3) an additional experiment was per-
formed. At constant BR and BLG concentrations (L/P
=0.22) the pH value of the solution was gradually raised
from 7.4 to 9.6 by addition of Wl volumes of concentrated
NaOH. Surprisingly, the intensities of the induced CD bands
were greatly enhanced during this process (Fig. 4); there was a
four-fold increase in the magnitudes of CE values, reaching vO
values of 386.5 (467 nm) and +77.1 (411 nm), while band
Fig. 2. Induced CD and UV/Vis spectra obtained by titration of
BLG (a mixture of A and B variants) with BR in pH 7.4 phosphate
bu¡er (for clarity, only selected curves are shown). Ligand was
added as aliquots of DMSO stock solution (cell length 1 cm;
t=20‡C). During the titration, concentration of BR was changed
from 2.5U1036 M to 4.2U1035 M, concentration of BLG was
changed from 9.0U1035 M to 8.8U1035 M. Insets: molar circular
dichroic absorption coe⁄cients (vO, in M31 cm31) and molar ab-
sorption coe⁄cients (O, in M31 cm31) of the induced CD and ab-
sorption bands calculated on the basis of total BR concentration in
solutions.
Fig. 3. CD titration curves of BLG A and the mixture of A and B
variants with BR in pH 7.4 phosphate bu¡er solution at 20‡C
(cBLG A = 9.1U1035 M, cBLG AþB = 9.0U1035 M; cell length 1 cm).
Ellipticity values measured at the maxima/minima of CEs are plot-
ted versus the L/Ps. Concentrations of BR were varied between
2.5U1036 and 3.7U1035 M, and between 2.5U1036 and 4.2U1035
M, respectively.
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shapes and wavelength positions remained the same (from a
pH value of 10.2, the CD intensities begin to decrease due to
the alkaline denaturation of BLG). Additionally, the magni-
tude of the visible absorption band of BR also increased at
higher pH values. To explain these results it must be taken
into account that BR has very limited aqueous solubility,
especially below pH 8 [28^31]. For example, its solubility
was reported to be about 1037 M in 0.1 M pH 7.4 phosphate
bu¡er [29]. At concentrations exceeding this value, BR shows
a strong tendency to self-associate, forming a colloidal solu-
tion, although the sample seems to be clear to the naked eye.
With higher pH values, however, the solubility increases and
more and more monomeric BR molecules enter into solution
[30,31]. Thus, at the concentrations used in the titration ex-
periment (from 2.5U1036 to 4.2U1035 M at pH 7.4) BR
molecules exist in three di¡erent states: molecules are bound
to BLG, unliganded molecules are truly in solution and a
certain fraction are in aggregated form. Titration data ob-
tained at pH 7.4 suggest that with increasing concentrations
of BR, equilibria between these states are shifted towards
formation of aggregates, resulting in constant induced CD
values (Fig. 3). Consequently, alkalization of the solution
changes this process oppositely, yielding higher and higher
ratios of monomeric molecules available for binding to BLG
(Fig. 4). Simultaneously, light absorption of BR increases as
well since the large aggregates, in which probability of photon
absorption of individual molecules is reduced, disintegrate
[32].
The pronounced optical activity of the BR^BLG complex
can be utilized to ascertain the protein binding site of BR. A
titration experiment was performed adding increasing
amounts of palmitic acid to the BR^BLG complex prepared
in phosphate bu¡er solution (pH 7.4, L/P= 0.28). Fatty acids,
the well-known endogenous ligands of BLG, were found by
X-ray crystallographic studies to occupy the central calyx
[13,14]. Upon addition of palmitic acid stock solution, the
magnitudes of the induced CD bands began to decrease and
they completely vanished above the value of 2.5 of fatty acid/
BR molar ratio (Fig. 5). According to this result, palmitic acid
molecules compete with BR for a common binding site of
BLG, namely for the central hydrophobic cavity.
The behavior of the induced CD spectrum upon an acidic
Fig. 4. Changes of the CD and UV/Vis spectra of the BR^BLG
complex formed in pH 7.4 phosphate bu¡er upon addition of Wl
volumes of 2 M NaOH (BR/BLG=0.23; cBLG = 8.9U1035 M,
cBR = 2.1U1035 M; cell length 1 cm; t=20 ‡C). Actual pH values,
Omax and vOmax=min of the absorption and CD bands are indicated
(BLG is the mixture of A and B variants).
Fig. 5. Titration of the BR^BLG complex with palmitic acid in
pH 7.4 phosphate bu¡er solution (L/P= 0.28; t=20‡C; cell length
1 cm). During the titration, concentration of palmitic acid was
changed from 9.8U1036 to 7.3U1035 M. Due to the addition of
palmitic acid solution cBLG was varied between 8.9U1035 and
8.7U1035 M and cBR was varied between 2.5U1035 and 2.4U1035
M (BLG is the mixture of A and B variants).
Fig. 6. pH dependence of the induced CD spectrum of the BR^
BLG complex formed in pH 7.4 phosphate bu¡er solution (L/
P=0.24; cBLG 8.9U1035 M, cBR 2.1U1035 M; t=20‡C). Dotted
line represents the spectrum of the reconstituted complex (pH 7.66)
obtained by adding 30 Wl 2 M NaOH to the slightly acidic (pH
6.49) solution (BLG is the mixture of A and B variants).
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pH shift leads to the same conclusion. Changing the pH value
of the bu¡er solution from 7.51 to 6.49, the amplitudes of the
induced CEs drop instantly down to zero. However, this pro-
cess is completely reversible since the induced CD bands ap-
pear again by setting the pH value back to 7.66 (Fig. 6). These
striking changes can be explained by the Tanford transition of
BLG [17]. In pH 7.51 solution, the EF loop located at the
entrance of the interior cavity is in an open conformation,
allowing dynamic binding of BR molecules in the hydropho-
bic pocket. Upon lowering of the pH, the EF loop £ips back,
blocking the access to the calyx and, due to unfavorable steric
interactions arising between BR molecule and protein side
chains, the complex dissociates. Since the EF loop movement
is entirely reversible, BR^BLG complexes and the correspond-
ing CD spectra can promptly be reconstituted by a small
volume of concentrated NaOH (Fig. 6).
4. Conclusions and perspectives
Performed in pH 7.4 phosphate bu¡er solution at 20‡C, CD
spectroscopy measurements demonstrated the binding of BR
to BLG. The protein acts as a chiral, water-soluble complex-
ation agent that binds this highly lipophilic pigment. As a
result of binding, oppositely signed induced CD CEs appear
which fall in the visible absorption region of the ligand. The
signed order of negative^positive CD bands derived from in-
tramolecular exciton coupling between dipyrrinone chromo-
phores of bound BR indicates selection of the BLG binding
site for a negative chirality (left-handed) conformer.
Binding in the central cavity, palmitic acid displaces BR
molecules. Additionally, conformational change of BLG dur-
ing Tanford transition leads to the dissociation of the pig-
ment-protein complex. Due to its molecular dimensions, BR
is probably not able to penetrate deeply into the interior cav-
ity; therefore, the £exible loop region of BLG might play an
important role not only in the recognition of BR but also in
its stabilization via non-covalent chemical interactions.
The main perspectives o¡ered by these results are as fol-
lows:
b The results that prove the ability of BLG to bind structur-
ally unrelated molecules, such as e.g. retinoic acid and BR,
serve as a good starting point to study what kind of struc-
tural elements are responsible for plasticity and promiscuity
of the ligand-binding mechanism of BLG.
b Comparing the structure of BLG with that of other lipo-
calins able to form complexes with tetrapyrrole molecules
[27,33] gives better insight into the problem as to how dis-
tinct amino acid sequences form sites which bind the same
ligand molecules.
b It can be expected that BLG binds not only BR but also
other tetrapyrroles and related compounds. Systematic in-
vestigations of such complexes would help to extend our
knowledge both of the molecular recognition mechanism
of lipocalins and of the stereochemical features of these
important pigment molecules.
b Because of its stability, abundance and ease of preparation,
BLG complexed with BR seems to be a promising subject
for X-ray crystallographic investigations [13,14].
b The dairy industry produces vast amounts of BLG (its con-
centration in cow milk is 5^6 g/l). Applying protein engi-
neering methods, the molecular recognition mechanism of
BLG could be modi¢ed to obtain small proteins uniquely
suited for detection, transport or separation of certain tet-
rapyrroles in biological samples.
b In severe cases of neonatal hyperbilirubinemia, when very
high levels of BR develop, exchange transfusion may be
needed, which has many disadvantages (the baby’s blood
is replaced with other, compatible blood). To reduce the
serum level of BR, patients’ blood should pass through
e.g. a column containing immobilized BLG molecules
which would bind the free, unconjugated BR. For repeated
use, the column would be regenerated by slightly acidic
bu¡er solution.
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